Cutting Edge: Probiotics and Fecal Microbiota Transplantation in Immunomodulation

被引:54
作者
Zeng, Wenjie [1 ,2 ]
Shen, Jie [3 ]
Bo, Tao [3 ]
Peng, Liangxin [1 ,2 ]
Xu, Hongbo [4 ]
Nasser, Moussa Ide [5 ]
Zhuang, Quan [1 ,6 ]
Zhao, Mingyi [3 ]
机构
[1] Cent South Univ, Xiangya Hosp 3, Transplantat Ctr, Changsha 410013, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Sch Med, Changsha 410013, Hunan, Peoples R China
[3] Cent South Univ, Xiangya Hosp 3, Pediat Dept, Changsha 410013, Hunan, Peoples R China
[4] Cent South Univ, Xiangya Hosp 3, Dept Surg, Changsha 410013, Hunan, Peoples R China
[5] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Cardiovasc Inst, Guangzhou 510100, Guangdong, Peoples R China
[6] Natl Hlth Minist Transplantat Med, Res Ctr, Changsha 410013, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1155/2019/1603758
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Probiotics are commensal or nonpathogenic microbes that confer beneficial effects on the host through several mechanisms such as competitive exclusion, antibacterial effects, and modulation of immune responses. Some probiotics have been found to regulate immune responses via immune regulatory mechanisms. T regulatory (Treg) cells, T helper cell balances, dendritic cells, macrophages, B cells, and natural killer (NK) cells can be considered as the most determinant dysregulated mediators in immunomodulatory status. Recently, fecal microbiota transplantation (FMT) has been defined as the transfer of distal gut microbial communities from a healthy individual to a patient's intestinal tract to cure some immune disorders (mainly inflammatory bowel diseases). The aim of this review was followed through the recent literature survey on immunomodulatory effects and mechanisms of probiotics and FMT and also efficacy and safety of probiotics and FMT in clinical trials and applications.
引用
收藏
页数:17
相关论文
共 146 条
[21]   Intragastric administration of Lactobacillus casei BL23 induces regulatory FoxP3+RORγt plus T cells subset in mice [J].
Cortes-Perez, N. G. ;
Lozano-Ojalvo, D. ;
Maiga, M. A. ;
Hazebrouck, S. ;
Adel-Patient, K. .
BENEFICIAL MICROBES, 2017, 8 (03) :433-438
[22]   Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis [J].
Cui, Bota ;
Li, Pan ;
Xu, Lijuan ;
Zhao, Youquan ;
Wang, Huiquan ;
Peng, Zhaoyuan ;
Xu, Hai'e ;
Xiang, Jie ;
He, Zhi ;
Zhang, Ting ;
Nie, Yongzhan ;
Wu, Kaichun ;
Fan, Daiming ;
Ji, Guozhong ;
Zhang, Faming .
JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
[23]  
DALLA MMS, 2012, IRAN J ALLERGY ASTHM, V11, P2
[24]   Probiotic Cell-Free Supernatants Exhibited Anti-Inflammatory and Antioxidant Activity on Human Gut Epithelial Cells and Macrophages Stimulated with LPS [J].
De Marco, Stefania ;
Sichetti, Marzia ;
Muradyan, Diana ;
Piccioni, Miranda ;
Traina, Giovanna ;
Pagiotti, Rita ;
Pietrella, Donatella .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
[25]   Subtractive screening for probiotic properties of Lactobacillus species from the human gastrointestinal tract in the search for new probiotics [J].
Delgado, S. ;
O'Sullivan, E. ;
Fitzgerald, G. ;
Mayo, B. .
JOURNAL OF FOOD SCIENCE, 2007, 72 (08) :M310-M315
[26]  
DENNISWALL J, 2002, THE AMERICAN JOURNAL, V105, P758, DOI DOI 10.3945/AJCN.116.140012
[27]   Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease [J].
Derwa, Y. ;
Gracie, D. J. ;
Hamlin, P. J. ;
Ford, A. C. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (04) :389-400
[28]  
DINIZ RO, 2002, PHARM RES, V47, P49, DOI DOI 10.1016/S1043-6618(02)00240-2
[29]  
EISEMAN B, 1958, SURGERY, V44, P854
[30]   Lactobacillus crispatus strain SJ-3C-US induces human dendritic cells (DCs) maturation and confers an anti-inflammatory phenotype to DCs [J].
Eslami, Solat ;
Hadjati, Jamshid ;
Motevaseli, Elahe ;
Mirzaei, Reza ;
Bonab, Samad Farashi ;
Ansaripour, Bita ;
Khoramizadeh, Mohammad Reza .
APMIS, 2016, 124 (08) :697-710